[Federal Register Volume 70, Number 42 (Friday, March 4, 2005)]
[Notices]
[Pages 10658-10659]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-4171]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Meeting; Interagency Autism Coordinating Committee

    The National Institutes of Health (NIH) hereby announces a meeting 
of the Interagency Autism Coordinating Committee to be held on May 16, 
2005, on the NIH campus in Bethesda, Maryland.
    The Children's Health Act of 2000 (Pub. L. 106-310), Title I, 
Section 104, mandated the establishment of an Interagency Autism 
Coordinating Committee (IACC) to coordinate autism research and other 
efforts within the Department of Health and Human Services (HHS). In 
April 2001, the HHS Secretary delegated the authority to establish the 
IACC to the NIH. Within the NIH, the National Institute of Mental 
Health (NIMH) is the designated lead for this activity.
    The IACC meeting will be open to the public, with attendance 
limited to space available. Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the contact person listed 
below in advance of the meeting.

    Name of Committee: Interagency Autism Coordinating Committee.
    Date: May 16, 2005.
    Time: 9 a.m.-4:30 p.m.
    Agenda: Discussion of autism activities across Federal agencies.
    Place: National Institutes of Health, 31 Center Drive, Building 
31, Conference Room 10 (6th floor), Bethesda, Maryland 20892.
    Contact Person: Ann Wagner, PhD, Division of Services and 
Intervention Research, NIMH, NIH, 6001 Executive Boulevard, Room 
7142, MSC 9633, Bethesda, Maryland 20892, E-mail: 
[email protected], Phone: 301-443-4283.
    Any member of the public interested in presenting oral comments 
to the Committee may notify Dr. Wagner, as listed above, at least 5 
days in advance of the meeting. Interested individuals and 
representatives of organizations may submit a letter of intent, a 
brief description of the organization represented, and a short 
description of the oral presentation. Presentations may be limited 
to 5 minutes; we request both printed and electronic copies for the 
record. In addition, any interested person may file written comments 
with the Committee by forwarding his or her statement to Dr.

[[Page 10659]]

Wagner, as listed above. The statement should include the name, 
address, telephone number, and, when applicable, the business or 
professional affiliation of the interested person.
    Information about the meeting and online registration forms are 
also available on the NIMH homepage at http://www.nimh.nih.gov/autismiacc/index.cfm.

    Dated: February 23, 2005.
Raynard S. Kington,
Deputy Director, National Institutes of Health.
[FR Doc. 05-4171 Filed 3-3-05; 8:45 am]
BILLING CODE 4140-01-P